Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies

Journal of Thrombosis and Haemostasis - Tập 1 - Trang 243-249 - 2003
M.E. Carr1, S.L. Carr1, T. Tildon1, L.MCA. Fisher1, E.J. Martin1
1*Coagulation Special Studies Laboratory, and Departments of †Medicine and ‡Pathology, Medical College of Virginia, VA, USA; §Virginia Commonwealth University, VA, USA; and ¶Richmond Veterans Administration Medical Center 5, Richmond, VA, USA

Tài liệu tham khảo

Buchanan, 1980, Prolonged bleeding time in children and young adults with hemophilia, Pediatrics, 66, 951, 10.1542/peds.66.6.951 Eyster, 1981, The bleeding time is longer than normal in hemophilia, Blood, 58, 719, 10.1182/blood.V58.4.719.719 Smith, 1985, The prolonged bleeding time in hemophilia A. Comparison of two measuring technics and clinical associations, Am J Clin Path, 83, 211, 10.1093/ajcp/83.2.211 Stuart, 1986, Bleeding time in hemophilia A. Potential mechanisms for prolongation, J Pediatr, 108, 215, 10.1016/S0022-3476(86)80985-4 Yamamoto, 1991, Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation, Blood, 77, 1740, 10.1182/blood.V77.8.1740.1740 Heiden, 1977, Impairment by heparin of primary haemostasis and platelet [14C]5-hydroxytryptamine release, Br J Haematol, 36, 427, 10.1111/j.1365-2141.1977.tb00666.x Carr, 1996, Heparin ablates force development during platelet mediated clot retraction, Thromb Haemost, 75, 674, 10.1055/s-0038-1650341 Carr, 1991, Measurement of platelet mediated force development during plasma clot formation, Am J Med Sci, 302, 13, 10.1097/00000441-199107000-00004 Carr, 1995, Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development, Blood Coagul Fibrinolysis, 6, 79, 10.1097/00001721-199502000-00013 Bonilla, 1975, Defibrinating enzyme from timber rattlesnake [Crotalus. J. horridus] venom: a potential agent for therapeutic defibrination, I Purification Properties Thromb Res, 6, 151 De Gaetano, 1973, Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction, Thromb Res, 2, 71, 10.1016/0049-3848(73)90081-9 Carr, 1994, At high heparin concentrations, protamine concentrations which reverse anticoagulant effects are insufficient to reverse heparin anti-platelet effects, Thromb Res, 75, 617, 10.1016/0049-3848(94)90174-0 Carr, 1993, Effect of non-heparin thrombin antagonists on platelet force development during clot retraction, Thromb Haemost, 69, 1241 Greilich, 1995, Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage, Anesth Analg, 80, 459 Clauss, 1957, A rapid physiological coagulation method for determination of fibrinogen, Acta Haematol, 17, 237, 10.1159/000205234 Carr, 1995, Measurement of platelet force: the Hemodyne Hemostasis analyzer, Clin Lab Manage Rev, 9, 312 Carr, 1994, Abnormal clot retraction, altered fibrin structure and normal platelet function in multiple myeloma, Am J Physiol, 266, H1195 Sikka, 1996, Congenital deficiency of factor VII, Indian J Pediatr, 63, 571, 10.1007/BF02905739 Weiss, 1988, Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained form bleeding time wounds, Blood, 71, 629, 10.1182/blood.V71.3.629.629 Green, 1983, Warfarin-induced factor VII deficiency and the bleeding time, Thromb Res, 29, 403, 10.1016/0049-3848(83)90243-8 Rand, 1998, Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting, Semin Thromb Hemost, 24, 523, 10.1055/s-2007-996051 Hoffman, 1998, Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII, Blood Coagul Fibrinolysis, 9, S61 Brody, 1975, Prolonged bleeding times with factor IX and XI deficiency von Willebrand's syndromes, Am J Med Sci, 269, 19, 10.1097/00000441-197501000-00003 Girolami, 1980, Normal platelet adhesiveness and aggregation in congenital PTA or Hageman factor deficiency, Folia Haematol Int Mag Klin Morph Blutforsch, 107, 487 Connellan, 1977, The role of factor XI in the coagulant activity of platelets, Haemostasis, 6, 41 Schiffman, 1977, FactorXI and platelets: Evidence that platelets contain only minimal factor XI activity and antigen, Br J Haematol, 35, 429, 10.1111/j.1365-2141.1977.tb00603.x Walsh, 1984, The possible role of platelets in bypassing the contact phase of blood coagulation, Haematologia (Budap), 17, 169 Weiss, 1984, Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency, Blood, 63, 1004, 10.1182/blood.V63.5.1004.1004 Janzarik, 1988, ‘Haemostasis time’, a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II: Application in bleeding disorders, Blut, 57, 111, 10.1007/BF00320149 Edgin, 1980, Acquired factor X deficiency with associated defects in platelet aggregation. A response to corticosteroid therapy, Am J Med, 69, 137, 10.1016/0002-9343(80)90512-4 Chu, 2000, In vitro characterization of a novel Xa inhibitor, RPR 130737, Thromb Res, 99, 71, 10.1016/S0049-3848(00)00227-9 Allen, 1999, Effect of varied procoagulant concentration on thrombin generation in a model system, Thromb Haemost Supplement, 1, 997 Allen, 2000, The effect of factor X level on thrombin geneartion and the procoagulant effect of activated factor VII in a cell-based model of coagulation, Blood Coagul Fibrinolysis Supplement, 1, S3, 10.1097/00001721-200004001-00002 Girolami, 1977, Platelet adhesiveness and aggregation in combined factor V and factor VIII deficiency and in combined factor VII and factor VIII deficiency, Folia Haematol Int Mag Klin Morph Bultforsch, 104, 663 Breederveld, 1975, The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency, Br J Haematol, 29, 405, 10.1111/j.1365-2141.1975.tb01838.x Tracy, 1987, Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders, Hum Pathol, 18, 162, 10.1016/S0046-8177(87)80334-9 Yang, 2000, Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression, Thromb Haemost, 83, 70, 10.1055/s-0037-1613760 Carr, 1976, Physical standard of fibrinogen: measurement of the elastic modulus of dilute fibrin gels with a new elastometer, Anal Biochem, 72, 202, 10.1016/0003-2697(76)90522-4 Shen, 1975, Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels, Thromb Res, 6, 255, 10.1016/0049-3848(75)90073-0